Brian Manby joined WisdomTree in October 2018 as an Investment Strategy Analyst. He is responsible for assisting in the creation and analysis of WisdomTree’s model portfolios, as well as helping support the firm’s research efforts. Prior to joining WisdomTree, he worked for FactSet Research Systems, Inc. as a Senior Consultant, where he assisted clients in the creation, maintenance and support of FactSet products in the investment management workflow. Brian received a B.A. as a dual major in Economics and Political Science from the University of Connecticut in 2016, and is pursuing the Chartered Financial Analyst designation.
Once fears of the delta variant subside and the recovery continues, we believe that small caps may continue as important pieces of the economic recovery. Until then, Brian Manby explains why investors should be wary of prevailing large-cap valuations in their portfolios.
At WisdomTree, we’ve preached the merits of quality exposure through U.S. markets for a long time. We believe there is now an historic opportunity to access quality in developed international markets. Brian Manby discusses.
No matter your economic forecast for the near future, Brian Manby explains why we think the WisdomTree U.S. MidCap Fund (EZM) could be a part of it.
For those looking to access the unique value opportunity in India, we prefer a strategy emphasizing these sectors as well as positive earnings in order to potentially benefit from continued economic growth. We believe the WisdomTree India Earnings Fund (EPI) may be able to deliver both.
Mapping the road ahead for any market environment is already hard enough, but it’s even more difficult this time as we finally exit the pandemic. No matter your economic forecast for the near future, Brian Manby explains why the WisdomTree U.S. SmallCap Fund (EES) can be a part of it.
We believe 2021 may mark a turning point for international equity markets. Brian Manby explains why investors should consider focusing on the quality factor when investing abroad.
